Hemolytic anemia blunts the cytokine response to transfusion of older red blood cells in mice and dogs.

These data suggest that underlying hemolysis blunts inflammatory responses to old RBC transfusions. The canine data support randomized trial results suggesting a lack of clinical benefit with fresh RBC transfusions in subjects with underlying, baseline hemolysis.